Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$134.26
-0.9%
$129.09
$119.59
$146.85
$14.91B0.911.06 million shs601,724 shs
DaVita Inc. stock logo
DVA
DaVita
$133.50
+0.5%
$132.12
$71.51
$141.54
$11.64B1.04798,575 shs477,665 shs
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$198.40
+0.0%
$211.70
$174.20
$234.09
$16.69B1.01758,681 shs931,285 shs
R1 RCM Inc. stock logo
RCM
R1 RCM
$11.90
+0.7%
$12.83
$8.87
$18.70
$5.01B0.783.61 million shs1.48 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-1.51%+7.58%+5.17%+3.85%-7.74%
DaVita Inc. stock logo
DVA
DaVita
+0.02%+5.28%-1.83%+23.89%+53.90%
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
-4.61%-0.55%-7.10%-11.77%-10.55%
R1 RCM Inc. stock logo
RCM
R1 RCM
-0.17%-1.66%-9.08%+14.20%-22.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.8695 of 5 stars
2.13.04.24.73.72.52.5
DaVita Inc. stock logo
DVA
DaVita
3.9723 of 5 stars
1.24.00.04.52.62.52.5
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
4.9187 of 5 stars
3.43.02.54.23.12.52.5
R1 RCM Inc. stock logo
RCM
R1 RCM
4.6917 of 5 stars
4.34.00.03.61.24.20.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.25
Hold$146.178.87% Upside
DaVita Inc. stock logo
DVA
DaVita
2.33
Hold$118.50-11.24% Downside
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
2.79
Moderate Buy$243.1422.55% Upside
R1 RCM Inc. stock logo
RCM
R1 RCM
2.62
Moderate Buy$16.8741.74% Upside

Current Analyst Ratings

Latest DGX, LH, DVA, and RCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$270.00 ➝ $255.00
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$234.00 ➝ $213.00
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$255.00 ➝ $244.00
4/25/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$138.00 ➝ $144.00
4/24/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$135.00 ➝ $145.00
4/24/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$139.00 ➝ $146.00
4/24/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$145.00 ➝ $150.00
4/24/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$150.00 ➝ $155.00
4/10/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00
4/10/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
4/5/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$9.25B1.61$12.44 per share10.79$58.25 per share2.30
DaVita Inc. stock logo
DVA
DaVita
$12.14B0.96$16.90 per share7.90$13.63 per share9.79
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$12.16B1.37$19.39 per share10.23$92.76 per share2.14
R1 RCM Inc. stock logo
RCM
R1 RCM
$2.25B2.22$0.69 per share17.28$6.56 per share1.81

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$854M$7.4318.0714.252.979.11%15.52%7.23%7/24/2024 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$691.53M$7.4018.0413.341.185.70%64.42%4.63%5/2/2024 (Confirmed)
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$418M$4.6742.4812.391.563.24%13.99%6.82%7/25/2024 (Estimated)
R1 RCM Inc. stock logo
RCM
R1 RCM
$3.30MN/A0.0079.33N/A0.15%0.12%0.07%5/8/2024 (Confirmed)

Latest DGX, LH, DVA, and RCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
R1 RCM Inc. stock logo
RCM
R1 RCM
-$0.05N/A+$0.05N/AN/AN/A  
5/2/2024N/A
DaVita Inc. stock logo
DVA
DaVita
$1.96N/A-$1.96N/AN/AN/A  
4/25/2024Q1 2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$3.46$3.68+$0.22$4.67$3.12 billion$3.18 billion    
4/23/2024Q1 2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$1.86$2.04+$0.18$2.36$2.29 billion$2.37 billion      
2/15/2024Q4 2023
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$3.29$3.30+$0.01$8.55$3.02 billion$3.03 billion    
2/13/2024Q4 23
DaVita Inc. stock logo
DVA
DaVita
$1.53$1.87+$0.34$2.12$3.01 billion$3.15 billion    
2/1/2024Q4 23
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.11$2.15+$0.04$2.60$2.25 billion$2.29 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.842.12%+8.08%38.22%13 Years
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$2.881.45%N/A61.67%N/A
R1 RCM Inc. stock logo
RCM
R1 RCM
N/AN/AN/AN/AN/A

Latest DGX, LH, DVA, and RCM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Quarterly$0.721.39%5/24/20245/28/20246/12/2024
2/1/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.752.34%4/5/20244/8/20244/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.59
0.97
1.20
DaVita Inc. stock logo
DVA
DaVita
6.65
1.19
1.13
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
0.52
1.17
1.02
R1 RCM Inc. stock logo
RCM
R1 RCM
0.57
1.83
1.83

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
DaVita Inc. stock logo
DVA
DaVita
90.12%
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
95.94%
R1 RCM Inc. stock logo
RCM
R1 RCM
61.10%

Insider Ownership

CompanyInsider Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.79%
DaVita Inc. stock logo
DVA
DaVita
1.40%
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
0.85%
R1 RCM Inc. stock logo
RCM
R1 RCM
36.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
48,000111.06 million110.18 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
70,00087.70 million86.47 millionOptionable
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
67,00084.13 million83.41 millionOptionable
R1 RCM Inc. stock logo
RCM
R1 RCM
30,000420.73 million265.90 millionOptionable

DGX, LH, DVA, and RCM Headlines

SourceHeadline
Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)
markets.businessinsider.com - April 25 at 7:42 PM
4 RCM companies making executive moves4 RCM companies making executive moves
beckershospitalreview.com - April 24 at 12:05 AM
Medical Billing Outsourcing Market to USD 41.9Bn by 2032, says Global Market Insights Inc.Medical Billing Outsourcing Market to USD 41.9Bn by 2032, says Global Market Insights Inc.
finance.yahoo.com - April 23 at 7:05 PM
Arkansas systems payer strategy sparked big financial turnaroundArkansas system's payer strategy sparked big financial turnaround
beckershospitalreview.com - April 23 at 7:05 PM
Oregon hospital plans layoffs amid RCM outsourcingOregon hospital plans layoffs amid RCM outsourcing
beckershospitalreview.com - April 23 at 7:05 PM
Availity taps R1 RCM exec as chief product officerAvaility taps R1 RCM exec as chief product officer
beckershospitalreview.com - April 22 at 3:22 PM
New York governor reaches deal to keep SUNY Downstate openNew York governor reaches deal to keep SUNY Downstate open
beckershospitalreview.com - April 21 at 8:42 AM
Mirae Asset Global Investments Co. Ltd. Sells 77,218 Shares of R1 RCM Inc. (NASDAQ:RCM)Mirae Asset Global Investments Co. Ltd. Sells 77,218 Shares of R1 RCM Inc. (NASDAQ:RCM)
marketbeat.com - April 19 at 4:39 AM
R1 RCM names VP of physician revenue cycle operationsR1 RCM names VP of physician revenue cycle operations
beckershospitalreview.com - April 18 at 12:58 PM
Sit Down Stand Up Olympian SpecialSit Down Stand Up Olympian Special
bbc.co.uk - April 18 at 7:57 AM
R1 RCM Inc. (NASDAQ:RCM) Shares Acquired by Voss Capital LLCR1 RCM Inc. (NASDAQ:RCM) Shares Acquired by Voss Capital LLC
marketbeat.com - April 15 at 7:23 PM
R1 RCM (NASDAQ:RCM) Given "Overweight" Rating at Cantor FitzgeraldR1 RCM (NASDAQ:RCM) Given "Overweight" Rating at Cantor Fitzgerald
marketbeat.com - April 10 at 11:26 AM
EUR/USD holds above 1.0860, eyes on US CPI, ECB rate decisionEUR/USD holds above 1.0860, eyes on US CPI, ECB rate decision
fxstreet.com - April 9 at 3:37 AM
Vista takes Model N private for $1.25BVista takes Model N private for $1.25B
axios.com - April 8 at 5:36 PM
Guggenheim Cuts R1 RCM (NASDAQ:RCM) Price Target to $15.00Guggenheim Cuts R1 RCM (NASDAQ:RCM) Price Target to $15.00
marketbeat.com - April 5 at 11:11 AM
Surgical Notes names former R1 RCM exec CFOSurgical Notes names former R1 RCM exec CFO
beckershospitalreview.com - April 4 at 1:37 PM
Inbox Health Announces Appointment of Kent Ivanoff to Board of DirectorsInbox Health Announces Appointment of Kent Ivanoff to Board of Directors
finance.yahoo.com - April 4 at 8:37 AM
Capstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial OfficerCapstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial Officer
finance.yahoo.com - April 3 at 5:36 PM
Capstreet-backed Surgical Notes taps Brignola as CFOCapstreet-backed Surgical Notes taps Brignola as CFO
pehub.com - April 3 at 12:35 PM
Surgical Notes taps new CFOSurgical Notes taps new CFO
beckersasc.com - April 3 at 12:35 PM
R1 RCM to Release First Quarter 2024 Results on May 8, 2024R1 RCM to Release First Quarter 2024 Results on May 8, 2024
globenewswire.com - April 1 at 5:00 PM
10 RCM headlines to know from March10 RCM headlines to know from March
beckershospitalreview.com - April 1 at 2:54 PM
Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)
markets.businessinsider.com - April 1 at 2:54 PM
Truist Financial Reiterates Hold Rating for R1 RCM (NASDAQ:RCM)Truist Financial Reiterates Hold Rating for R1 RCM (NASDAQ:RCM)
marketbeat.com - April 1 at 9:10 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Quest Diagnostics logo

Quest Diagnostics

NYSE:DGX
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DaVita logo

DaVita

NYSE:DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Laboratory Co. of America logo

Laboratory Co. of America

NYSE:LH
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
R1 RCM logo

R1 RCM

NASDAQ:RCM
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.